358 related articles for article (PubMed ID: 24519448)
1. Efficacy of cryotherapy associated with laser therapy for decreasing severity of melphalan-induced oral mucositis during hematological stem-cell transplantation: a prospective clinical study.
de Paula Eduardo F; Bezinelli LM; da Graça Lopes RM; Nascimento Sobrinho JJ; Hamerschlak N; Correa L
Hematol Oncol; 2015 Sep; 33(3):152-8. PubMed ID: 24519448
[TBL] [Abstract][Full Text] [Related]
2. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
[TBL] [Abstract][Full Text] [Related]
3. Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.
Blijlevens N; Schwenkglenks M; Bacon P; D'Addio A; Einsele H; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vokurka S; Quinn B; McCann S;
J Clin Oncol; 2008 Mar; 26(9):1519-25. PubMed ID: 18268357
[TBL] [Abstract][Full Text] [Related]
4. The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-l-PAM 200 mg/m(2) autologous hematopoietic stem cell transplantation.
Vokurka S; Bystricka E; Scudlova J; Mazur E; Visokaiova M; Vasilieva E; Brandejsova R; Chvojkova I; Vrabcova M; Vitkova J; Mjartanova D; Vodickova M; Bockova J; Streinerova K
Eur J Oncol Nurs; 2011 Dec; 15(5):508-12. PubMed ID: 21310656
[TBL] [Abstract][Full Text] [Related]
5. Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma.
Batlle M; Morgades M; Vives S; Ferrà C; Oriol A; Sancho JM; Xicoy B; Moreno M; Magallón L; Ribera JM
Eur J Haematol; 2014 Dec; 93(6):487-91. PubMed ID: 24889275
[TBL] [Abstract][Full Text] [Related]
6. Icing oral mucositis: Oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant.
Chen J; Seabrook J; Fulford A; Rajakumar I
J Oncol Pharm Pract; 2017 Mar; 23(2):116-120. PubMed ID: 26684614
[TBL] [Abstract][Full Text] [Related]
7. Ice-cream used as cryotherapy during high-dose melphalan conditioning reduces oral mucositis after autologous hematopoietic stem cell transplantation.
Jasiński M; Maciejewska M; Brodziak A; Górka M; Skwierawska K; Jędrzejczak WW; Tomaszewska A; Basak GW; Snarski E
Sci Rep; 2021 Nov; 11(1):22507. PubMed ID: 34795377
[TBL] [Abstract][Full Text] [Related]
8. Oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: clinical outcomes in a context of specialized oral care using low-level laser therapy.
Eduardo Fde P; Bezinelli LM; de Carvalho DL; Lopes RM; Fernandes JF; Brumatti M; Vince CS; de Azambuja AM; Vogel C; Hamerschlak N; Correa L
Pediatr Transplant; 2015 May; 19(3):316-25. PubMed ID: 25677170
[TBL] [Abstract][Full Text] [Related]
9. Effects of cryotherapy on high-dose melphalan-induced oral mucositis in pediatric patients undergoing autologous stem cell transplantation.
Kawaguchi K; Umeda K; Takachi T; Ogura T; Horikoshi Y; Saida S; Kato I; Hiramatsu H; Adachi S; Takita J; Watanabe K
Pediatr Blood Cancer; 2020 Sep; 67(9):e28495. PubMed ID: 32573946
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of oral cryotherapy on oral mucositis prevention in patients with hematological malignancies undergoing hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials.
Wang L; Gu Z; Zhai R; Zhao S; Luo L; Li D; Zhao X; Wei H; Pang Z; Wang L; Liu D; Wang Q; Gao C
PLoS One; 2015; 10(5):e0128763. PubMed ID: 26024220
[TBL] [Abstract][Full Text] [Related]
11. Efficiency of supersaturated calcium phosphate mouth rinse treatment in patients receiving high-dose melphalan or BEAM prior to autologous blood stem cell transplantation: a single-center experience.
Waśko-Grabowska A; Rzepecki P; Oborska S; Barzał J; Gawroński K; Młot B; Szczylik C
Transplant Proc; 2011 Oct; 43(8):3111-3. PubMed ID: 21996239
[TBL] [Abstract][Full Text] [Related]
12. Early salivary changes in multiple myeloma patients undergoing autologous HSCT.
van Leeuwen S; Proctor GB; Potting C; Ten Hoopen S; van Groningen L; Bronkhorst EM; Blijlevens N; Huysmans M
Oral Dis; 2018 Sep; 24(6):972-982. PubMed ID: 29637662
[TBL] [Abstract][Full Text] [Related]
13. A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
Lilleby K; Garcia P; Gooley T; McDonnnell P; Taber R; Holmberg L; Maloney DG; Press OW; Bensinger W
Bone Marrow Transplant; 2006 Jun; 37(11):1031-5. PubMed ID: 16633359
[TBL] [Abstract][Full Text] [Related]
14. Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model.
Grazziutti ML; Dong L; Miceli MH; Krishna SG; Kiwan E; Syed N; Fassas A; van Rhee F; Klaus H; Barlogie B; Anaissie EJ
Bone Marrow Transplant; 2006 Oct; 38(7):501-6. PubMed ID: 16980998
[TBL] [Abstract][Full Text] [Related]
15. Severity of oral mucositis in patients undergoing hematopoietic cell transplantation and an oral laser phototherapy protocol: a survey of 30 patients.
Eduardo FP; Bezinelli L; Luiz AC; Correa L; Vogel C; Eduardo CP
Photomed Laser Surg; 2009 Feb; 27(1):137-44. PubMed ID: 18699729
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of cryotherapy against oral mucositis among allogeneic hematopoietic stem cell transplant recipients using melphalan-based conditioning.
Oku S; Futatsuki T; Imamura Y; Hikita H; Inada A; Mizutani S; Mori Y; Kashiwazaki H
Support Care Cancer; 2023 Aug; 31(9):521. PubMed ID: 37581845
[TBL] [Abstract][Full Text] [Related]
17. Variability of high-dose melphalan exposure on oral mucositis in patients undergoing prophylactic low-level laser therapy.
Rodrigues GH; Jaguar GC; Alves FA; Guollo A; Camandoni VO; Damascena AS; Lima VCC
Lasers Med Sci; 2017 Jul; 32(5):1089-1095. PubMed ID: 28512727
[TBL] [Abstract][Full Text] [Related]
18. Preliminary study in a new protocol for the treatment of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT).
Vitale MC; Modaffari C; Decembrino N; Zhou FX; Zecca M; Defabianis P
Lasers Med Sci; 2017 Aug; 32(6):1423-1428. PubMed ID: 28664389
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Low-Level Laser Therapy on Oral Mucositis and Quality of Life in Patients Undergoing Hematopoietic Stem Cell Transplantation Using the Oral Health Impact Profile and the Functional Assessment of Cancer Therapy-Bone Marrow Transplantation Questionnaires.
Silva LC; Sacono NT; Freire Mdo C; Costa LR; Batista AC; Silva GB
Photomed Laser Surg; 2015 Jul; 33(7):357-63. PubMed ID: 26154723
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation.
Kim KI; Kim JW; Lee HJ; Kim BS; Bang SM; Kim I; Oh JM; Yoon SS; Lee JS; Park S; Kim BK
Am J Hematol; 2013 Feb; 88(2):107-12. PubMed ID: 23225026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
